Novanta Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1B+8.5% YoYTTM through 3 Jul 2026
Net Income $61.8M-3.6% YoYTTM through 3 Jul 2026
Free Cash Flow $114.3MTTM through 3 Jul 2026
Margins
| Current | |
|---|---|
| Gross Margin | 44.1% |
| EBITDA Margin | 14.9% |
| Operating Margin | 10.7% |
| Net Margin | 6.0% |
Returns
3.8%ROE
2.9%ROA
5.5%ROIC
Balance Sheet Health
Debt / Equity0.14x
Current Ratio4.57x
Net Debt-$147.4Mnet cash position
Cash & Equivalents$718.7M
Quality Metrics
Altman Z-Score7.60
Piotroski F-Score6 / 9
FCF Margin11.1%
Rule of 4021.2
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $980.6M
Diluted EPS$1.58TTMFY2025: $1.47
Dividend
No dividend
Capital Allocation
R&D Spend$94.2M
Capex Intensity1.9%
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.